Icon (ICLR) Stock: Buy, Sell, or Hold?
ICLR - Icon Plc
$162.05
0.20 (0.12%)
â˛
5d:
-5.97%
30d:
+1.38%
90d:
-5.2%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Oct 28, 2026
25d
Get Alerted When ICLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ICLR is fairly priced but lacks strong directional signals. At 4.6% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ICLR is fairly priced but lacks strong directional signals. At 4.6% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$206.66
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$128.32
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICLR is currently trading at $162.05, which is considered slightly high relative to its 30-day fair value range of $163.21 to $172.54. From a valuation perspective, the stock is trading at a premium (Forward PE: 13.7) compared to its historical average (12.0). At these levels, the market is pricing in 4.6% annual earnings growth.
Technical Outlook: Technically, ICLR is in a strong uptrend. The price is currently testing key support at $160.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $186.76 (+15.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ICLR is in a strong uptrend. The price is currently testing key support at $160.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $186.76 (+15.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$163.21 -
$172.54
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.2%
Protect Your Profits
Holding ICLR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($186.76)
- BULLISH: Expecting earnings turnaround to 4.6% growth with 1.2% revenue growth
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$163.21 -
$172.54
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$160.41
Resistance Level
$176.70
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.69
Wall Street Target
$186.76
(+15.4%)
Revenue Growth (YoY)
1.2%
Earnings Growth (YoY)
-63.3%
Profit Margin
0.3%
Valuation Premium vs History
+4.6% premium
PE vs Historical
13.7 vs 12.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.6%
(market-implied from PE analysis)
1-Year Target
$169.30
(+5%)
2-Year Target
$177.08
(+9%)
3-Year Target
$185.23
(+14%)
3-Yr Target (if PE normalizes)
(PE: 14â12)
PE COMPRESSION
$162.34
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 11.7%)
$336.40
(+108%)
Base:
(SPY PE: 13.7, Growth: 11.7%)
$225.78
(+40%)
Bear:
(PE: 11.6, Growth: 11.7%)
$191.91
(+19%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Forward PE: 14.75 | Forward EPS (Implied): $10.97
Bull Case
$195.43
(+21%)
Analyst growth 15.0%, PE expands to 15.5
Base Case
$161.85
(0%)
Market implied 0.0%, PE stable at 14.8
Bear Case
$123.82
(-24%)
Severe decline -15.0%, PE contracts to 13.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 02, 2026 3:58 PM ET
Data refreshes hourly during market hours. Next update: 4:58 PM
Data refreshes hourly during market hours. Next update: 4:58 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$653 | 49 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 48 HOLD |
|
LH
Laboratory Corporation oâĻ |
STRONG BUY
20 analysts |
$345 | 67 BUY |
Advanced ICLR Option Strategies
Professional options setups generated by AI based on today's ICLR price and gamma walls.
